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Background: The search for alternative therapies for oral candidiasis is a necessity and the use of medicinal plants
seems to be one of the promising solutions. The objective of this study was to evaluate the in vitro and in vivo
effects of the essential oil of Melaleuca alternifolia on Candida albicans.
Methods: The minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) of
M. alternifolia were determined by the broth microdilution assay. For the in vivo study, twelve immunosuppressed
mice with buccal candidiasis received topical applications of M. alternifolia with MBEC. After treatment, yeasts were
recovered from the mice and quantified (CFU/mL). Mice were killed for morphologic analysis of the tongue dorsum
by optical and scanning electron microscopy. Data were analyzed using Student’s t test or Mann-Whitney test.
Results: The MIC of M. alternifolia was 0.195% and the MBEC was 12.5%. Treatment with M. alternifolia achieved a
5.33 log reduction in C. albicans and reduced the microscopic lesions of candidiasis.
Conclusions: M. alternifolia oil at a 12.5% was effective to eradicate a C. albicans biofilm formed in vitro and to
reduce yeasts of C. albicans in an immunosuppressed mouse model.
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Recent decades have seen a significant increase in the in-
cidence of all forms of candidiasis. This increase reflects
changes in medical practice with more frequent use of
invasive surgical procedures, and more widespread use
of immunosuppressive therapies and broad-spectrum
antibiotics [1]. However, key to the increase in oral can-
didiasis has been the expansion of acquired immunodefi-
ciency syndrome (AIDS) worldwide [1]. Oral candidiasis is
the most common fungal infection in patients with AIDS
and it usually indicates the progression of HIV infection
[2-4]. Treatment of oral candidiasis in HIV-positive pa-
tients is difficult because of recurring episodes, intermit-
tent exposure and continual selection of antifungal* Correspondence: dennisrossoni@hotmail.com
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article, unless otherwise stated.therapy-resistant strains. Studies have shown that C. albi-
cans and non-albicans strains are developing resistance to
the antifungals widely used for treatment of oral candidia-
sis, such as fluconazole and amphotericin B [5,6].
Another aspect related to antifungal resistance and the
recurrence of infection is the ability of Candida spp. to
form biofilms on various surfaces in the oral cavity. A bio-
film has been defined as a community of microorganisms
organized at interfaces, enclosed in a self-produced poly-
meric matrix and adhered to an inert or living tissue. The
presence of an exopolymeric matrix couple with the
organization of layers of cells may confer protection of or-
ganisms in the inner layers, thereby contributing to anti-
fungal resistance [7-9]. For example, biofilms formed
in vitro by C. albicans on silicone catheters were sensitive
to micafungin only at a concentration 100 to 500 times
higher than the minimum inhibitory concentration (MIC)
in planktonic cells [10].Med Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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is a necessity and the use of medicinal plants seems to
be one of the promising solutions [11,12]. The plant
Melaleuca alternifolia has been used as an antiseptic
remedy for decades. Although there is no published
documentation of specific medicinal applications for M.
alternifolia by Aboriginals prior to the colonization of
Australia, the Bundjalung Aboriginals of New South
Wales used the plant for medicinal purposes and spoke
of the wound healing properties of the water from a lake
into which M. alternifolia leaves had fallen [13]. The es-
sential oil of M. alternifolia, termed tea tree oil, contains
almost hundreds components, the majority of which are
monoterpenes and related alcohols. It has a minimum
content of 30% of terpinen-4-ol and a maximum content
of 15% of 1,8-cineole. Terpinen-4-ol is a major M. alterni-
folia component and exhibits strong antimicrobial and
anti-inflammatory properties, whereas 1,8-cineole is prob-
ably an undesirable allergen in M. alternifolia products
[14]. Preliminary trials suggest that M. alternifolia formu-
lations may be effective in the treatment of acne and fun-
gal infections, and in bacterial pathogen decolonization
protocols [13]. The antimicrobial activity of M. alternifolia
is attributed to its ability to denature proteins and alter
the properties and function of the cell wall membrane,
leading to the loss of intracellular components and even-
tually cell death [15-17].
Several in vitro studies described the antifungal activity
of M. alternifolia against Candida isolates in planktonic
growth, with MICs typically between 0.5-2% (v/v) [17] and
showed inhibition of germ tube formation by C. albicans
[18]. Few studies were performed in vivo to confirm and
strengthen the in vitro results [19,20]. Because M. alterni-
folia shows promise as a topical anti-candidal therapy and
its antimicrobial effects depend on the concentration used
[17], the aim of this study was to determine the minimal
concentration of M. alternifolia required to eradicate
C. albicans biofilms formed in vitro and to study the ef-
fects of this concentration in treating oral candidiasis in-
duced in an immunosuppressed mouse model.
Methods
Microbial strains and culture conditions
C. albicans strain ATCC 18804 was used for all experi-
mental assays in this study. This strain was stored as fro-
zen stocks in 30% glycerol at -80°C, subcultured on
Sabouraud Dextrose agar plates and routinely grown in
Sabouraud liquid medium at 37°C.
M. alternifolia essential oil
M. alternifolia was purchased at the Federal University
of Viçosa/UFV. The UFV has the botanical identification
of the plant studied, as well as its own deposit in a herbar-
ium voucher specimen of the University, with registrationnumber 30839 corresponding to M. alternifolia. The oil
was obtained by the steam distillation technique. The
oil sample contained the following major components:
terpinen-4-ol (42.8%), γ-terpinene (20.4%), p-cymene
(9.6%), α-terpinene (7.9%), 1,8-cineole (3%), α-terpineol
(2,8%) and α-pinene (2.4%) as determined by gas chro-
matography mass spectrometry [21].
In vitro activity of M. alternifolia essential oil:
Determination of Minimal Inhibitory Concentration (MIC)
in planktonic culture
The MIC of M. alternifolia was determined by the broth
microdilution method according to the Clinical and
Laboratory Standards Institute (CLSI) [22] document M27-
A2. Initially, C. albicans were grown in Sabouraud dextrose
agar for 48 h at 37°C. Then, the yeast suspension was pre-
pared in 5 mL sterile saline (0.85%) and the cellular density
was adjusted to 0.284 using a spectrophotometer (B582,
Micronal, São Paulo, Brazil) at wavelength = 530 nm, result-
ing in a standard solution with 1 × 106 cells/mL. The stand-
ard solution was diluted 1:50 in RPMI 1640 medium with
L-glutamine without sodium bicarbonate and buffered with
0.165 M morpholinepropanesulfonic acid (MOPS; Sigma-
Aldrich, Steinheim, Germany), followed by a 1:20 dilution
to obtain a final concentration of 1-5 × 103 cells/mL.
Eleven serial 1:2 dilutions were made from the M.
alternifolia into a 96-well plate (25 to 0.01% (v/v)) from
100 μL of M. alternifolia in 100 μL of culture medium
RPMI 1640 at pH 7.0 ± 0.1. Subsequently, 100 μL of the
standardized suspension of C. albicans were added to
each well of 96-well plate. A well for positive control
(medium with inoculum) and another well for negative
control (medium alone) were included.
Tween-80 (final concentration 0.001% v/v) was included
to facilitate oil solubility [19]. The plates were incubated at
37°C for 24 h. Minimal inhibitory concentration (MIC)
was determined in the well of lowest concentration, in
which turbidity was not observed when compared to oil-
free growth control. This experiment was performed inde-
pendently in triplicate.
In vitro activity of M. alternifolia essential oil:
Determination of Minimal Biofilm Eradication
Concentration
C. albicans biofilms were formed in vitro using the meth-
odology described by Seneviratne et al. [23] with some
modifications. Cultures of C. albicans grown on Sabouraud
dextrose agar (Himedia) at 37°C for 18h were harvested in
yeast nitrogen base (YNB, Himedia) supplemented with 50
mM glucose (Vetec, Duque de Caxias, RJ, Brazil). After an
18 h incubation at 37°C , yeasts were centrifuged at 358 × g
for 10 minutes, washed twice with PBS, resuspended with
YNB supplemented with 100 mM glucose and adjusted to
an optical density of 0.381 at 530 nm (107 cells/mL) using a
Table 1 Design of the study of in vivo activity of




Day 1 1° injection of prednisolone
Day 2 Inoculation of C. albicans in the oral cavity of mice
Day 5 2° injection of prednisolone
Day 6 Treatment of oral candidiasis with M. alternifolia
essential oil or physiological solution (control group)
Recovery of C. albicans from the tongue dorsum
of mice before and immediately after
experimental treatment
Day 7 Euthanasia of the mice: macroscopic analysis, optical
microscopy, and Scanning Electron Microscopy
(SEM) of the tongue dorsum of mice.
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C. albicans suspension was pipetted into each well of a 96-
well flat-bottom microtiter plate (Costa Corning). The plate
was incubated for 90 min at 37°C in a shaker at 75 rpm
(Quimis, Diadema, Brazil) for the initial adhesion phase.
After this period, the wells were washed with 250 μL of
PBS to removed loosely adherent cells. A 250 μL aliquot
of YNB supplemented with 100 mM glucose was then
pipetted into each washed well, and the plates were incu-
bated at 37°C in a shaker at 75 rpm for 48 h. The broth
was changed every 24 h. Plates with biofilms formed by C.
albicans were washed with 250 μL of PBS to remove
loosely adherent cells.
The biofilm formed in each well was immersed in 250
μL of M. alternifolia suspended in 1% Tween 80 for 5
min in an orbital shaker (Solab, Piracibaca, Brazil). The
concentration of M. alternifolia tested ranged from the
MIC to 25%. The biofilm of the control group was pipet-
ted with phosphate buffered saline (PBS) for the same
period of time. All tests were performed in triplicate.
After treatments with M. alternifolia, biofilm cells were
scraped off the well wall using a sterile toothpick and
transferred to Falcon tubes containing 10 mL PBS. To dis-
rupt the biofilms, the contents of the tubes were homoge-
nized for 30 s using an ultrasonic homogenizer (Sonoplus
HD 2200, Badelin Electronic, Berlim, Germany) with an
output power of 50 W. The solution in the Falcon tubes
was considered to be diluted by a factor of 10−1. Serial di-
lutions were then made using each original 10−1 dilution,
and aliquots of 0.1mL were seeded onto Sabouraud dex-
trose agar (Himedia) plates that were incubated at 37°C
for 48 h. After the incubation period, CFU/mL values were
determined for each plate. Minimal biofilm eradication
concentration was defined as the lowest concentration of
oil that resulted in complete inhibition of CFU/mL.
Analysis of C. albicans biofilms formed in vitro by
Scanning Electron Microscopy (SEM)
Biofilms of C. albicans treated with the minimal biofilm
eradication concentration of TTO (n = 2) and treated
with PBS as a control group (n = 2) were subjected to
SEM analysis.
Biofilms were formed and treated by M. alternifolia as
described above with a minor modification: biofilms were
formed on polystyrene discs approximately 8 mm in diam-
eter that had been previously sterilized in a 20 -kGy
gamma radiation chamber (cobalt 60) for 6 h (Embrarad,
São Paulo, Brazil). The discs were placed into 24-well
plates (Costa Corning, New York, USA) in which the total
volume of suspension, PBS, broth culture and essential oil
was 1 mL. The discs were transferred after biofilm forma-
tion to 24-well plates fixed in 2.5% glutaraldehyde for 1 h
and dehydrated in several ethanol washes (10, 25, 50, 75
and 90% for 20 min each and 100% for 60 min). The plateswere then incubated at 37°C for 24 h to dry the discs. The
discs were transferred to aluminium stubs and covered
with gold for 120 s at 40 mA (BAL-TEC 50D 050 Sputter
Coater, Liechtenstein). After metallization, the biofilms
were examined and photographed by SEM (Jeol JSM
5600, Tokyo, Japan) operating at 15 kV in increments of
1000 and 5000 times.
In vivo activity of M. alternifolia essential oil in oral
candidiasis induced in an immunosuppressed
mouse model
All animal experiments were conducted in accordance
with the policies for animal care, welfare, and use of the
Institute of Science and Technology/UNESP and to the
Declaration of Helsinki. This study was approved by the
Research Ethics Committee of the Institute of Science
and Technology/UNESP (protocol number 024/2009-
PA/CEP). Twenty-four adult male mice (Mus musculus,
Albinus, Swiss) with twelve-week-old that tested nega-
tive for the Candida genus in the oral cavity, weighing
approximately 30 to 60 g, were included in the study.
Animals were divided into 2 groups: treated with TTO
(n = 12) and treated with physiological solution (n =12).
In each group, 10 mice were used for analysis by optical
microscopy and 2 mice were used for scanning electron
microscopy. The design of the experiments is shown in
Table 1.Induction of experimental candidiasis
The methodology described by Takakura et al. [24] was
used to induce experimental candidiasis with some modi-
fications. Briefly, animals were immunosuppressed with 2
subcutaneous injections of prednisolone (Depo-Medrol,
laboratórios Pfizer Ltda., Guarulhos, SP, Brazil) at a dose of
100 mg/kg of body weight 1 day before and 3 days after in-
fection with Candida. Tetracycline chloride (Terramicina,
Laboratórios Pfizer Ltda., Guarulhos, SP, Brazil) was
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0.83 mg/mL beginning 1 day before infection and was
maintained throughout the experiment. A 50 μL intramus-
cular injection of chlorpromazine chloride (10 mg/kg of
body weight; Amplictil, Sanofi Aventis, Suzano, SP, Brazil)
in each thigh was used to sedate the animals.
C. albicans grown for 24 h at 37°C on Sabouraud dex-
trose agar (Himedia, Mumbai, Maharashtra, India) was
resuspended in 10 mL PBS and centrifuged at 358xg for
10 minutes. The pellet was resuspended in 10 mL PBS
and adjusted to 108 cells/mL after counting in a Neubauer
chamber (Laboroptik GMBH, Bad Homburg, Germany).
A sterile swab (Absorve, Cral, São Paulo, SP, Brazil) soaked
in the C. albicans suspension was used to inoculate the se-
dated mice by rubbing the swab for 1 minute on the
tongue dorsum.
Treatment of experimental oral candidiasis with M.
alternifolia essential oil
At 4 days post C. albicans inoculation, animals were
anesthetized by intramuscular injection of ketamine
(União Química, São Paulo, Brazil) at a concentration of
100 mg/kg of body weight and Xylazine (Produtos
Veterinários J. A. Ltda., Patrocínio Paulista, SP, Brazil) at
a dose of 10 mg/kg body weight. The minimal biofilm
eradication concentration of M. alternifolia determined
by the in vitro assay (12.5%) was used to treat oral can-
didiasis. M. alternifolia was suspended in 1% Tween 80
and pipetted onto the dorsum of the tongue in 50 μL for
3 times in intervals of 10 minutes. The control group re-
ceived physiological solution in the same volume and
with the same frequency.
Recovery of C. albicans from the tongue dorsum of mice
Samples from the tongue dorsum were collected with a
mini-swab before and immediately after each experimental
treatment, the swab was placed in a test tube containing
0.99 mL PBS and shaken for 1 minute. This solution was
estimated to be diluted by a factor of 10−2 Candida from
the soaked swab. Serial dilutions were subsequently made,
and 0.1 mL of each dilution was plated onto the surface of
Sabouraud dextrose agar (Himedia) containing chloram-
phenicol (Viximicina, São Paulo, SP, Brazil). Dilutions
were plated in duplicate and incubated at 37°C for 48
hours. Candida colonies were counted on plates exhibit-
ing 30 to 300 colonies to determine colony-forming
units (CFU)/mL. Plates with fewer than 30 colonies
from the initial 10−2 dilution were estimated to contain
10−1 Candida cells.
Euthanasia of the mice
One day after the experimental treatment, an excessive
dose of anesthetic, 100 mg/kg body weight ketamine (União
Química Farmacêutica Nacional S/A., Embu-Guaçu, SP,Brazil) and 10 mg/kg body weight xylazine (Produtos
Veterinários J. A. Ltda., Patrocínio Paulista, SP, Brazil) was
administered to kill the mice, corresponding to 5 days
after experimental candidiasis induction. Tongues were re-
moved for macroscopic and microscopic analyses (optical
and scanning electron microscopy, respectively).
Macroscopic analysis of candidiasis on the tongue
dorsum of mice
Characteristic lesions of candidiasis on the tongue dorsum
were observed using a stereomicroscope (Zeiss, Göttingen,
Germany). For quantification of lesions on the tongue dor-
sum, scores were assigned from 0 to 4: 0, normal; 1, white
patches on less than 20% of the surface; 2, white patches
covering between 21% and 90% of the surface; 3, white
patches on more than 91% of the surface; and 4, thick
white patchy pseudomembranes covering more than 91%
of the surface [24].
Optical microscopy of the tongue dorsum of mice
For microscopic analysis of the lesions, the tongues
were fixed in 10% formalin for 24 h. After embedding in
paraffin, 5 μm-thick tissue slices were cut and stained
with hematoxylin-eosin (H&E) and periodic acid-Schiff
(PAS). The presence of candidiasis was analyzed using
optical microscopy (Olympus, CX41, Toquio, Japan) at
X400 magnification.
Candidiasis lesions were quantified by counting the
number of hyphae and epithelial lesions in histological
sections stained with PAS and H&E, respectively. For
each stain, two histological sections were selected ran-
domly and analyzed from each animal. In each histo-
logical section, 21 histologic fields were analyzed in the
anteroposterior direction in 42 histologic fields.
The presence of yeasts and hyphae was quantified ac-
cording to the methodology of Junqueira et al. [25], at-
tributing the following scores to histologic fields: 1, 1 to
5 yeasts/hyphae; 2, 6 to 15 yeasts/hyphae; 3, 16 to 50
yeasts/hyphae; and 4, more than 50 yeasts/hyphae. For
statistical analysis, a median of the scores obtained from
the 42 histologic fields was determined per animal.
The intensity of the tissue lesions was evaluated by
counting the number of histologic fields with the pres-
ence of epithelial lesions, such as epithelial hyperplasia,
disorganization of the basal cell layer, exocytosis, spon-
giosis, loss of filiform papillae, hyperkeratosis and devel-
opment of intraepithelial microabscesses. The mean of
the number of histologic sections with epithelial lesions
was determined per animal for statistical analysis.
Scanning electron microscopy (SEM) of the tongue
dorsum of mice
For SEM analysis, tongues were fixed in 2.5% glutaralde-
hyde in phosphate buffer (0.1 mol/L and pH 7.3) for 24
Figure 1 Scanning electron microscopy (SEM) of C. albicans
biofilms formed in vitro on the polystyrene discs. The biofilm
formed after 48 h was composed of blastoconidia, pseudohyphae
and hyphae (Control group).
Figure 2 Number of fungal cells before and after with M.
alternifolia treatment. Means and standard deviations of the CFU/mL
of C. albicans recovered from the oral cavity of the mice before and
after experimental treatment (n = 10 per group). The recovery of C.
albicans was performed immediately after treatment with M. alternifolia.
*Significant difference between the number of CFU/mL recovered
before and after treatment with TTO (Student’s t-test, P = 0.001).
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salt solution (0.85% NaCl) for 30 minutes. Specimens
were subsequently dehydrated in a series of ethanol so-
lutions (50%, 70%, and 90% for 20 minutes each and
100% for 20 minutes 3 times). After dehydration, ton-
gues were dried to the critical point using CO2 (Denton
Vacuum DCP 1, Moorestown, NJ). The tongues were
then fixed on aluminum stubs and coated with gold for
120 seconds at 40 mA (BAL-TEC 50 D 050 Sputter
Coater, Liechtenstein) and evaluated using SEM (JEOL
JSM 5600, Tóquio, Japan) at 15 kV. The images obtained
from SEM analyses were evaluated only to identify
yeasts, hyphae and tissue damage that characterize the
experimental candidiasis induced in immunosuppressed
mouse model. No quantification of Candida or epithelial
lesions was performed.
Statistical analysis of the data obtained from
experimental candidiasis
The data obtained from the recovered CFU/mL and
quantification of epithelial lesions using optical micros-
copy were analyzed by Student’s t test. The scores from
the macroscopic analysis and the quantification of yeasts
and hyphae in optical microscopy were evaluated using
the non-parametric Mann-Whitney test. A P value less
than 0.05 was considered statistically significant.
Results
In vitro activity of M. alternifolia essential oil
The effects of M. alternifolia on the in vitro growth of
C. albicans were first examined following the CLSI.
Among the tested concentrations of M. alternifolia (0.01
to 25%), the MIC value was determined to be 0.195%
(1.95 mg/mL). After determination of the MIC, concen-
trations of M. alternifolia ranging from 0.195 to 25%
were tested on C. albicans biofilms, and 12.5% was de-
termined to be the minimal biofilm erradication concen-
tration. To confirm complete inhibition of C. albicans
biofilms after treatment with 12.5% M. alternifolia, the
biofilms were analyzed by scanning electron microscopy
(SEM). In SEM analysis, no formation of hyphae or blas-
toconidia was observed in the biofilms treated with
M. alternifolia. However, a heterogeneous biofilm com-
posed of blastoconidia, pseudohyphae and hyphae was
observed on the polystyrene discs in the control group
without M. alternifolia treatment (Figure 1).
In vivo activity of M. alternifolia essential oil
The numbers of C. albicans recovered from the oral cav-
ity of mice before and immediately after experimental
treatments with M. alternifolia or physiological solution
(control group) are shown in Figure 2. The group treated
with M. alternifolia showed a 5.33 Log10 reduction in
the number of C. albicans cells after treatment, whilethe control group had a 0.24 Log10 reduction after appli-
cation of physiological solution, indicating that the
essential oil of M. alternifolia significantly reduced the
colonization by C. albicans in the oral cavity of mice.
After 24 h of experimental treatments, macroscopic
analysis of the tongue dorsum showed the presence of
candidiasis lesions characterized by pseudomembranous
white plaques (Figure 3) in both experimental groups
(treated with M. alternifolia and control) with a median
Figure 3 Macroscopic lesions of candidiasis on the tongue
dorsum characterized by pseudomembranous white plaques.
Figure 4 Macroscopic analysis of candidiasis on the tongue
dorsum of mice. Scores obtained from the macroscopic analysis of
candidiasis on the tongue dorsum of mice after 24 h of the treatment
with essential oil of M. alternifolia or physiological solution for the
control group (n = 10 per group). The scores were attributed according
to Takakura el al. 2003 as follows: Score 0 (normal), Score 1 (white
patches on less than 20% of the surface), Score 2 (white patches
covering between 21% and 90% of the surface), Score 3 (white patches
on more than 91% of the surface) and Score 4 (thick white patchy
pseudomembranes covering more than 91% of the surface). There
were no significant differences between the groups treated with
M. alternifolia oil and control (Mann-Whitney test, P = 0.3662).
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21% and 90% of the tongue surface. In all mice studied,
only scores 1 and 2 were identified. Although the number
of animals receiving score 2 in the group treated with
M. alternifolia was lower when compared to the control
group, this difference was not significant (Figure 4). These
data demonstrated that candidiasis lesions persisted for 24
h after treatment with essential oil of M. alternifolia.
In optical microscopy analysis, candidiasis lesions were
represented by the presence of yeasts and hyphae limited
to the keratinized layer on the tongue dorsum (Figure 5).
In these regions, the epithelial tissue showed loss of fili-
form papillae, microabscesses, exocytosis, spongiosis, basal
layer disorganization, epithelial hyperplasia, and an in-
creased number of mitoses in the basal layer. Muscle
inflammation, inflammatory infiltrate and some congested
blood vessels in the lamina propria were also observed.
The hyphae and yeasts were quantified in histological
sections stained by PAS (Figure 6). Although the median
scores obtained for the M. alternifolia and control groups
were scored 1 and 2, respectively, no statistically signifi-
cant difference was observed between groups treated with
M. alternifolia and control (P = 0.2596). The epithelial le-
sions were also quantified using histological sections
stained by H&E (Figure 7), and it was observed that the
group treated with M. alternifolia showed fewer candidia-
sis lesions when compared to the control group, this dif-
ference was statistically significant (P = 0.005).
SEM analysis on the tongue dorsum showed a large
quantity of bacteria, yeasts and hyphae. Yeasts appeared in
less quantity than hyphae and some hyphae were penetrat-
ing the epithelial tissue (Figure 8). In some regions, thefiliform papillae were damaged, while papillae were lost in
others, showing that the animals developed well-established
candidiasis lesions on the tongue dorsum.
Discussion
Numerous essential oils such as M. alternifolia oil have
been tested for both their in vitro and in vivo antifungal
activity. M. alternifolia has been traditionally used by
Australian natives and more recently, it has become a
popular essential oil used as a non-ethnic remedy
worldwide [12,20]. In this study, we demonstrated that
the essential oil of M. alternifolia at a 12.5% concentration
completely inhibited the C. albicans biofilms formed
in vitro and had a protective effect against oral C. albicans
infections in mice.
M. alternifolia has demonstrated activity against
C. albicans [17-20]. New studies that can identify and
evaluate the clinical effectiveness of M. alternifolia need
be developed, such as assays with different experimental
models and cell lines by evaluating the cytotoxicity, vari-
ous concentrations and combinations with conventional
antifungal agents to verify the possible synergism. Our
findings can contribute in the future to prove M. alternifo-
lia as an adjuvant clinical therapy, especially in cases of
Candida lesions that is the most frequent fungal condition
among humans living with HIV.
First, the in vitro effects of M. alternifolia on C. albi-
cans were examined by the broth microdilution method
Figure 5 Sagittal section of the dorsum of the tongue of mice. A) Control group - Hyphae of C. albicans in the keratin layer (arrows) and
areas of exocytosis (arrow head). B) M. alternifolia group - Yeasts of C. albicans in the keratin layer (arrows) and intraepithelial microabscesses (*).
PAS staining, 400X magnification.
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According to Carson et al. [13], the MICs of M. alternifo-
lia for yeasts generally range between 0.03 and 0.5%, while
fungicidal concentrations generally range from 0.12 to 2%.
In addition to inhibiting the growth of Candida, some
studies have shown that M. alternifolia inhibits the forma-
tion of germ tubes and decreased the cell surface hydro-
phobicity of C. albicans [13,17,18]. Hammer et al. [18]
verified that germ tube formation was affected by the pres-
ence of sub-inhibitory concentrations of M. alternifolia
oil, and it was completely inhibited by the presence of
0.25% TTO. Sudjana et al. [17] investigated the effects of
the oil from M. alternifolia on C. albicans cell adhesion toFigure 6 Microscopic analysis of candidiasis on the tongue
dorsum of mice. Scores obtained from optical microscopy of
histological sections stained by PAS after 24 h of the treatment with
essential oil of M. alternifolia or physiological solution for the control
group (n = 10 per group). Scores were attributed according to
Junqueira et al. 2005: Score 1 (1 to 5 yeasts/hyphae), Score 2 (6 to
15 yeasts/hyphae), Score 3 (16 to 50 yeasts/hyphae), and Score 4
(more than 50 yeasts/hyphae). There were no significant differences
between the groups treated with M. alternifolia oil and control
(Mann-Whitney test, P = 0.2596).both abiotic and biotic surfaces. Adhesion of C. albicans
to polystyrene was significantly reduced for 3 isolates at
0.031%, 6 isolates at 0.062% and 0.125% and for all 7 iso-
lates studied at 0.25% M. alternifolia. Similarly, adhesion
to buccal epithelial was also significantly reduced in the
presence of 0.016-0.062% M. alternifolia.
Essential oil mouthwashes containing a range of natural
plant extracts, including thymol, eucalyptol, bioflavanoids
and M. alternifolia oil derivatives, demonstrated direct
bactericidal and anticandidal activity in vitro. It is thought
that essential oil mouthwashes kill microorganisms by cell
membrane disruption and enzyme inhibition. However,
the effectiveness of natural antimicrobials on establishedFigure 7 Means and standard deviations of epithelial lesions
obtained from optical microscopy. Means and standard
deviations obtained from optical microscopy of histological sections
stained by H&E after 24 h of the treatment with essential oil of
M. alternifolia or physiological solution for the control group. The
number of histological fields with the presence of epithelial lesions
was determined for each animal studied (n = 10 per group). *A
significant difference between the groups was observed (Student’s
t-test, P = 0.005).
Figure 8 Scanning electron microscopy of the tongue dorsum. A) Control group - Hyphae of C. albicans (arrows) penetrating the tissue of
the tongue dorsum after 24 h of the treatment with physiological solution. B) M. alternifolia group -Yeasts of C. albicans (arrows) on the tissue of
the tongue dorsum after 24 h of the treatment with M. alternifolia oil.
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penetration by the agents being reported. The clinical effi-
cacy of essential oil mouthwashes has been studied, but
largely against plaque bacteria. Therefore, the clinical ben-
efits of these agents in treating oral candidiasis remain to
be established [1].
In this study, we determined the minimal concentra-
tion of M. alternifolia oil necessary to eradicate C. albi-
cans biofilms formed in vitro. The minimal biofilm
eradication concentration (MBEC) was 12.5%, equivalent
to 64 times the MIC. Budzynska et al. [11] also evalu-
ated the minimal inhibitory concentration (MIC) and
the minimal biofilm eradication concentration (MBEC)
of M. alternifolia in biofilms formed by Staphylococcus
aureus. The MIC value was 0.38%, and the authors
achieved an MBEC concentration of 173 times the MIC
for 1 h of treatment, whereas 8 times the MIC was suffi-
cient to obtain a 90% reduction in biomass metabolic
activity after 4 h of treatment.
After establishing the MBEC, we tested the in vivo ef-
fects of M. alternifolia at a 12.5% concentration on oral
candidiasis. For this, we used an experimental model of
oral candidiasis in immunosuppressed mice developed by
Takakura et al. [24]; this model is an established method-
ology that is widely used by several authors for the study of
this infection [20,26-29]. In the control group of this study,
a large number of viable Candida cells (5-6 Log10) were re-
covered from the oral cavity of mice. This finding is in
agreement with studies by Costa et al. [28] and Ninomiya
et al. [20] that recovered 5-6 Log10 Candida cells from the
oral cavity of animals.
In contrast, a relatively low number of C. albicans cells
was recovered from the oral cavity of mice treated with
M. alternifolia. The treatment with this essential oil re-
sulted in a 5.33 Log10 reduction of C. albicans, indicat-
ing clinical efficacy of M. alternifolia for the treatment
of oral candidiasis. Ninomiya et al. [20] also studied theeffects of M. alternifolia on oral candidiasis in an im-
munosuppressed mouse model and found an approxi-
mate 1 Log10 reduction of C. albicans after treatment
with M. alternifolia at concentrations of 1 and 4%. Prob-
ably, the highest Candida reduction observed in our
study was achieved by the concentration of M. alternifo-
lia tested (12.5%).
According to Hammer et al. [30], while the antimicro-
bial properties of M. alternifolia oil are increasingly
well-characterized, relatively limited data are available
on the safety and toxicity of this oil. Greay et al. [31]
showed that topical treatments of 10% M. alternifolia
had significant activity against subcutaneous tumours in
immunocompetent mice. The antitumor effect of topical
M. alternifolia was accompanied by skin irritation simi-
lar to other topical chemotherapeutic agents, but unlike
other approved topical agents, this irritation was quickly
resolved. Furthermore, topical M. alternifolia caused an
influx of neutrophils in the treated area, with no evi-
dence of systemic toxicity. The lack of systemic activity
within the treatment period was verified by normal
body weigth, no changes in serum alkaline phosphatase
or aspartate aminotransferase and normal liver hist-
ology of the animals studied.
Clinical evidence suggests that topical use of the oil is
relatively safe and that adverse events are minor, self-
limiting and occasional [30]. In a study conducted by
Veien et al. [32], 217 patients consecutively sampled in a
dermatology clinic were patch-tested with 10% M. alter-
nifolia with no irritant reactions recorded. Catalán et al.
[33] tested 20% M. alternifolia to identify the in vitro
and in vivo activity of this oil mixed with different tissue
conditioners on the C. albicans strain. In the in vitro
study, these authors verified that Coe-Comfort or Fitt
conditioners mixed with M. alternifolia exhibited total
inhibition of C. albicans. Patients treated with M. alter-
nifolia mixed with Coe-Comfort in an in vivo study
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when compared to those treated with Coe-Comfort alone.
However, M. alternifolia can be toxic if ingested, as evi-
denced by studies with experimental animals and from
cases of human poisoning [34,35]. The 50% lethal dose for
M. alternifolia in a rat model is 1.9 to 2.6 mL/Kg. Inci-
dences of oral poisoning in children and adults have been
reported, and in all cases, patients responded to supportive
care and recovered without apparent sequelae [13].
In this study, M. alternifolia was suspended in 1%
Tween 80 to be applied on the dorsum of the tongue.
Tween 80, a nonionic surfactant and an emulsifier, is fre-
quently used as a carrier for M. alternifolia. Considering
the biological effects of Tween 80 in experimental oral
candidiasis treated by M. alternifolia, Ninomiya et al.
[20,36] used 1% Tween 80 as control group and found
similar results of C. albicans CFU/mL compared to
other studies of oral candidiasis in immunosuppressed
mice that used physiological solution as control group.
Several studies showed that Tween 80 has low toxicity
for human cells and experimental animals [37,38]. In
addition, its application is permitted for intradermal and
intravenous injection in human beings [38].
After verifying that M. alternifolia at concentration of
12.5% significantly reduced the C. albicans colonization
in the oral cavity of mice, we tested the effects of M.
alternifolia treatment on the candidiasis lesions and tis-
sue repair. Therefore, mice were killed 24 hours after the
treatment and the tongues were removed for macroscopic
and microscopic analyses. In these analyses, we verified
that the animals treated with M. alternifolia showed fewer
candidiasis lesions when compared to untreated animals
(control group). Despite this, no statistically significant dif-
ference was observed for the macroscopic analysis and
quantification of hyphae (histological sections stained by
PAS) between M. alternifolia and control-treated groups.
Only the quantification of epithelial lesions (histological
sections stained by H&E) showed a statistically significant
difference between groups.
However, Ninomiya et al. [20] found a significant reduc-
tion in the macroscopic lesions of the dorsum tongue for
groups treated with M. alternifolia. This difference might
be attributed to the time of M. alternifolia application in
relation to the stage of candidiasis infection. Ninomiya
et al. [20] applied M. alternifolia on the dorsum tongue at
3 and 24 h after infection by C. albicans. Because it is
known that C. albicans form germ tubes and hyphae 3
hours after inoculation in experimental oral candidiasis
[39], Ninomiya et al. [20] may have found a significant re-
duction in macroscopic lesions because M. alternifolia
prevented Candida invasion of the epithelium by hyphae.
These data suggest that early administration of M. alterni-
folia is highly effective. In the present study, M. alternifo-
lia was applied 4 days after infection by C. albicans.Therefore, oral candidiasis lesions were already well-
established, and consequently impaired the action of
M. alternifolia. Furthermore, we evaluated candidiasis
lesions on the dorsum tongue 24 h after application of
M. alternifolia, and this time period may not have been
long enough for improvement of the lesions and tissue
repair to occur.
Conclusions
In this study, we concluded that M. alternifolia oil at a
12.5% concentration was effective to eradicate a C. albi-
cans biofilm formed in vitro and to reduce yeasts of
C. albicans in an immunosuppressed mouse model.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: RDR, VMCR, ACBPC, CFA, PPB,
ALA. Performed the experiments: JCJ, RDR, ACBPC, VMCR. Analyzed the data:
JCJ, ACBPC, VMCR, AOCJ, ALA. Contributed reagents/materials/analysis tools:
JCJ, AOCJ. Wrote the paper: RDR, JCJ, ALA, AOCJ. All authors read and
approved the final manuscript.
Acknowledgments
The authors thank Prof. Antônio Lelis Pinheiro for his assistance with the
preparation of M. alternifolia essential oil and Prof. Oslei Paes de Almeida and
Adriano Luis Martins for their assistance with scanning electron microscopy of the
dorsum tongue. We acknowledge the São Paulo Council of Research - FAPESP,
Brazil (Grants 2010/19117-7, 2010/06602-4 and 2012/02184-9) for supporting
this research.
Received: 29 April 2014 Accepted: 10 December 2014
Published: 15 December 2014
References
1. Williams DW, Kuriyama T, Silva S, Malic S, Lewis MA: Candida biofilms and oral
candidosis: treatment and prevention. Periodontol 2000 2011, 55:250–265.
2. Naglik JR, Fidel PL Jr, Odds FC: Animal models of mucosal Candida
infection. FEMS Microbiol Lett 2008, 283:129–139.
3. Souza RC, Junqueira JC, Rossoni RD, Pereira CA, Munin E, Jorge AO:
Comparison of the photodynamic fungicidal efficacy of methylene blue,
toluidine blue, malachite green and low-power laser irradiation alone
against Candida albicans. Lasers Med Sci 2010, 25:385–389.
4. Junqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa AC, Rasteiro VM,
Suleiman JM, Jorge AO: Oral colonization by yeasts in HIV-positive
patients in Brazil. Rev Inst Med Trop Sao Paulo 2012, 54:17–24.
5. Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D,
Erlandsen J, Redding SW, Patterson TF: Oropharyngeal candidiasis in the
era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2010, 109:488–495.
6. Schelenz S, Abdallah S, Gray G, Stubbings H, Gow I, Baker P, Hunter PR:
Epidemiology of oral yeast colonization and infection in patients with
hematological malignancies, head neck and solid tumors. J Oral Pathol
Med 2011, 40:83–89.
7. Seneviratne CJ, Jin L, Samaranayake LP: Biofilm lifestyle of Candida: a mini
review. Oral Dis 2008, 14:582–590.
8. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA: Antifungal
susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid
formulations and echinocandins. Antimicrob Agents Chemother 2002,
46:1773–1780.
9. Dovigo LN, Pavarina AC, Mima EG, Giampaolo ET, Vergani CE, Bagnato VS:
Fungicidal effect of photodynamic therapy against fluconazole-resistant
Candida albicans and Candida glabrata. Mycoses 2011, 54:123–130.
10. Cateau E, Berjeaud JM, Imbert C: Possible role of azole and echinocandin
lock solutions in the control of Candida biofilms associated with silicone.
Int J Antimicrob Agents 2011, 37:380–384.
de Campos Rasteiro et al. BMC Complementary and Alternative Medicine 2014, 14:489 Page 10 of 10
http://www.biomedcentral.com/1472-6882/14/48911. Budzyńska A, Wieckowska-Szakiel M, Sadowska B, Kalemba D, Rózalska B:
Antibiofilm activity of selected plant essential oils and their major
components. Pol J Microbiol 2011, 60:35–41.
12. Harris R: Progress with superficial mycoses using essential oils. The
International Journal of Aromatherapy 2002, 12:83–91.
13. Carson CF, Hammer KA, Riley TV: Melaleuca alternifolia (Tea Tree) oil: a
review of antimicrobial and other medicinal properties. Clin Microbiol Rev
2006, 19:50–62.
14. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A: A review of applications
of tea tree oil in dermatology. Int J Dermatol 2013, 52:784–790.
15. Cox SD, Mann CM, Markham JL: Interactions between components of the
essential oil of Melaleuca alternifolia. J Appl Microbiol 2001, 91:492–497.
16. Carson CF, Mee BJ, Riley TV: Mechanism of action of Melaleuca alternifolia
(tea tree) oil on Staphylococcus aureus determined by time-kill, lysis,
leakage, and salt tolerance assays and electron microscopy.
Antimicrob Agents Chemother 2002, 46:1914–1920.
17. Sudjana AN, Carson CF, Carson KC, Riley TV, Hammer KA: Candida albicans
adhesion to human epithelial cells and polystyrene and formation of
biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree)
essential oil. Med Mycol 2012, 50:863–870.
18. Hammer KA, Carson CF, Riley TV: Melaleuca alternifolia (tea tree) oil
inhibits germ tube formation by Candida albicans. Med Mycol 2000,
38:355–362.
19. Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G: In vivo
activity of terpinen-4-ol, the main bioactive component of Melaleuca
alternifolia cheel (tea tree) oil against azole-susceptible and -resistant
human pathogenic Candida species. BMC Infect Dis 2006, 6:158.
20. Ninomiya K, Maruyama N, Inoue S, Ishibashi H, Takizawa T, Oshima H, Abe S:
The Essential oil of Melaleuca alternifolia (Tea Tree Oil) and its main
component, terpinen-4-ol protect mice from experimental oral
candidiasis. Biol Pharm Bull 2012, 35:861–865.
21. Pereira TS, Sant’Ana JR, Silva EL, Pinheiro AL, Castro-Prado MAC: In vitro
genotoxicity of Melaleuca alternifolia essential oil in human lymphocytes.
J Ethnopharmacol 2014, 151:852–857.
22. NCCLS (National Committee for Clinical Laboratory Standards): Reference
method for broth dilution antifungal susceptibility testing of yeasts. Approved
standard - second edition. M27-A2. Wayne, PA, USA: 2002.
23. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP:
Architectural analysis, viability assessment and growth kinetics of
Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009,
54:1052–1060.
24. Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, Abe S: A
novel murine model of oral candidiasis with local symptoms
characteristic of oral thrush. Microbiol Immunol 2003, 47:321–326.
25. Junqueira JC, Colombo CE, Martins Jda S, Koga Ito CY, Carvalho YR, Jorge
AO: Experimental candidosis and recovery of Candida albicans from the
oral cavity of ovariectomized rats. Microbiol Immunol 2005, 49:199–207.
26. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T: Protective effects of
human saliva on experimental murine oral candidiasis. J Infect Chemother
2004, 10:253–255.
27. Hayama K, Ishibashi H, Kitadate K, Yamazaki M, Abe S: Therapeutic effect of
oligonol, a low-molecular polyphenol formulation derived from lychee
fruits on murine oral candidiasis. Nihon Ishinkin Gakkai Zasshi 2010,
51:137–142.
28. Costa AC, Campos Rasteiro VM, da Silva Hashimoto ES, Araújo CF, Pereira CA,
Junqueira JC, Jorge AO: Effect of erythrosine- and LED-mediated
photodynamic therapy on buccal candidiasis infection of immunosup-
pressed mice and Candida albicans adherence to buccal epithelial cells.
Oral Surg Oral Med Oral Pathol Oral Radiol 2012, 114:67–74.
29. Costa AC, Pereira CA, Junqueira JC, Jorge AO: Recent mouse and rat
methods for the study of experimental oral candidiasis. Virulence 2013,
4:391–399.
30. Hammer KA, Carson CF, Riley TV, Nielsen JB: A review of the toxicity of
Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 2006, 44:616–625.
31. Greay SJ, Ireland DJ, Kissick HT: Inhibition of established subcutaneous
murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.
Cancer Chemother Pharmacol 2010, 66:1095–1102.
32. Veien NK, Rosner K, Skovgaard GL: Is tea tree oil an important contact
allergen? Contact Dermatitis 2004, 50:378–379.
33. Catalán A, Pacheco JG, Martínez A, Mondaca MA: In vitro and in vivo
activity of Melaleuca alternifolia mixed with tissue conditioner onCandida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008,
105:327–332.
34. Morris MC, Donoghue A, Markowitz JÁ, Osterhoudt KC: Ingestion of tea
tree oil (Melaleuca oil) by a 4-year-old boy. Pediatr Emerg Care 2003,
19:169–171.
35. Moss A: Tea tree oil poisoning. Med J Aust 1994, 160:236.
36. Ninomiya K, Hayama K, Ishijima AS, Maruyama N, Irie H, Kurihara J, Abe S:
Suppression of inflammatory reactions by Terpinen-4-ol, a main constituent
of Tea Tree Oil, in a murine model of oral candidiasis and its suppressive
activity to cytokine production of macrophages in vitro. Biol Pharm Bull 2013,
36:838–844.
37. Arechabala B, Coiffard C, Rivalland P, Coiffard LJ, de Roeck-Holtzhauer Y:
Comparison of cytotoxicity of various surfactants tested on normal
human fibroblast cultures using the neutral red test, MTT assay and LDH
release. J Appl Toxicol 1999, 19:163–165.
38. Bulcão RP, de Freitas FA, Dallegrave E, Venturini CG, Baierle M, Durgante J,
Sauer E, Cassini C, Cerski CT, Zielinsky P, Salvador M, Pohlmann AR, Guterres
SS, Garcia SC: In vivo toxicological evaluation of polymeric nanocapsules
after intradermal administration. Eur J Pharm Biopharm 2014, 86:167–177.
39. Hisajima T, Ishibashi H, Yamada T, Nishiyama Y, Yamaguchi H, Funakoshi K,
Abe S: Invasion process of Candida albicans to tongue surface in early
stages of experimental murine oral candidiasis. Med Mycol 2008,
46:697–704.
doi:10.1186/1472-6882-14-489
Cite this article as: de Campos Rasteiro et al.: Essential oil of Melaleuca
alternifolia for the treatment of oral candidiasis induced in an
immunosuppressed mouse model. BMC Complementary and Alternative
Medicine 2014 14:489.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
